{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T19:20:48Z","timestamp":1648927248590},"reference-count":0,"publisher":"Ecancer Global Foundation","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3332\/ecancer.2013.378","type":"journal","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T09:57:07Z","timestamp":1481191027000},"source":"Crossref","is-referenced-by-count":0,"title":["ecancermedicalscience"],"prefix":"10.3332","member":"1871","container-title":[],"original-title":[],"link":[{"URL":"http:\/\/ecancer.org\/journal\/7\/pdf\/378-one-for-the-road-a-study-to-assess-the-efficacy-of-single-low-dose-regimen-of-rasburicase-in-controlling-hyperuricaemia-in-patients-with-tumour-lysis-syndrome-due-to-haematological-malignancies.php","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T09:57:07Z","timestamp":1481191027000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ecancer.org\/journal\/7\/full\/378-one-for-the-road-a-study-to-assess-the-efficacy-of-single-low-dose-regimen-of-rasburicase-in-controlling-hyperuricaemia-in-patients-with-tumour-lysis-syndrome-due-to-haematological-malignancies.php"}},"subtitle":[],"short-title":["ecancer"],"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.3332\/ecancer.2013.378","relation":{},"ISSN":["1754-6605"],"issn-type":[{"value":"1754-6605","type":"electronic"}],"subject":[]}}